以生技醫療照護為關注重點的比翼加速器 (BE Accelerator)與北醫加速器共同經營的 PoC (Proof of Clinical Evidence) Program，加速新創團隊走入Healthcare ecosystem！

不管是概念與產品驗證、定位產品服務、專業臨床諮詢輔導、建立商業模式、鏈結國際、媒合資金及媒體曝光，並有機會獲得北醫生醫加速器新創投資基金，在新創資金及專業臨床輔導雙重資源挹注下，加速新創團隊提升企業價值

詳細內容：https://bit.ly/TMU2023Batch

🌟計畫亮點🌟

 ✔臨床功能驗證實察

提供臨床試驗規劃、需求驗證以及醫療法規諮詢等

✔結合臨床數據與健保資料庫

促進生醫研究、輔導技能與降低產品開發風險

✔促進新創與臨床醫師合作

提供臨床場域與專業醫師，輔導團隊臨床試驗研發策略

✔鏈結新創與醫院資源

輔導建立醫療通路、落地國內外市場

📆截至日期：2022/12/31

⚡️按下連結『立即申請』：https://bit.ly/TMU2023Batch

Taipei Medical University BioMed Accelerator and BE Health Ventures have co-launched TMU X BE Accelerator Program, which is a POC (Proof of Clinical Evidence) Program that focuses on product or prototype-ready startups that are looking for traction in the Asian market. Based in Taipei, Taiwan we leverage the unique strengths of our ecosystem to position our accelerator program as the gateway to Asia.

For details, please click the following URL: https://bit.ly/TMU2023Batch

🌟Program Highlight🌟

 ✔Clinical function verification

Provide clinical trial, demand verification, field pilot verification, and medical regulatory consultation, etc.

✔Combine clinical data and health insurance database

Promote biomedical research, coaching skills and reduce product development risks.

✔Promote collaboration between startups and physicians

Combining the resources of hospitals to provide clinical trial research and development strategies for the clinical field and professional physician counselling team.

✔Link startups and hospital resources

Establish medical channels and land in local and international markets.

📆 Deadline：Till 2022/12/31

⚡️ Apply Now：https://bit.ly/TMU2023Batch